Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Concurrent Technologies launches compact military computer system

(Sharecast News) - Concurrent Technologies announced the launch of 'Apollo', a compact computer system designed for real-time processing in demanding environments, including military and aerospace applications, on Tuesday. The AIM-traded firm said Apollo, weighing 3.6 kilograms, was designed for deployment in confined spaces and could be rapidly integrated into platforms such as medium-sized drones.

It said it incorporates time sensitive networking capabilities to deliver low-latency, predictable performance, supporting applications that require precise real-time responses.

The system combines technologies from Concurrent's two business units - the products division supplied a range of customisable single board computers, while the systems division designed the mission-critical chassis, meeting strict reliability standards and providing power, conduction cooling and adaptable input/output configurations.

"Through close collaboration with our customers, particularly in the US, we are confident that this system will fulfil a need that is currently not well serviced in the market," said chief revenue officer Brent Salgat.

"The modular design and configurable interfaces combined with the ease of deployment and use, offer a strong competitive advantage.

"We are encouraged by the early interest."

Concurrent said Apollo reflected the growing demand for 'edge' computing solutions that combine agility, processing power and rapid deployability in operational environments.

At 1321 BST, shares in Concurrent Technologies were up 4.61% at 193p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.